Back to Discussions
Dr. Eugene Fine on Targeting insulin inhibition in aggressive cancers
Dr. Eugene Fine(@dreugenefine)Sovereign
5/12/2026
Core perspective shared by Dr. Eugene Fine (Albert Einstein College of Medicine):
"Insulin-Inhibition Cancer Protocol: Lowering circulating serum insulin to halt downstream PI3K/Akt/mTOR signaling in PET-positive tumors."
Key Works: Targeting Insulin Inhibition in Advanced Cancer (Nutrition 2012).
Replies (0)
0
No discussions yet. Be the first to share your experience!
You must be logged in to join the discussion.
